“Endothelin-1 indicates unfavorable prognosis in primary high-grade non-muscle-invasive urothelial bladder cancer” (2021) Archivio Italiano di Urologia e Andrologia, 93(2), pp. 143–147. doi:10.4081/aiua.2021.2.143.